A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

To assess the long-term safety and tolerability of ACP-103 in subjects with Parkinson's disease psychosis.

Kusajili – Clinical trials directory